Clinical trials
Leukemia, B-Cell trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| German CLL Study Group | 5 |
| AstraZeneca | 3 |
| Bristol-Myers Squibb | 2 |
| Novartis Pharmaceuticals | 2 |
| Acerta Pharma BV | 1 |
| Celgene | 1 |
| Celgene Corporation | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Loxo Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Non-Hodgkin | 4 |
| Recurrence | 4 |
| Lymphoma, B-Cell | 3 |
| Multiple Myeloma | 3 |
| Neoplasms | 3 |
| Leukemia | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Ependymoma | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.